To include your compound in the COVID-19 Resource Center, submit it here.

Zepatier lands co-exclusive status on Express Scripts 2019 formulary

Express Scripts Holding Co. (NASDAQ:ESRX) announced its 2019 National Preferred Formulary Exclusions, noting that the exclusions were driven not only by the size of the rebate as in years past, but also by lower list prices, garnering

Read the full 375 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers